News & Events
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine
By Dana Elimelech
The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.